PepsiCo, Inc.
Letter data
- Company
- PepsiCo, Inc.
- Recipient
- Ramon Laquarta | CEO | PepsiCo, Inc. | The Quaker Oats Co. | 700 Anderson Hill Road | Purchase | , | NY | 10577 | United States | Ramon.laguarta@pepsico.com
- Issue date
- 2024-09-10
- Posted date
- Not available
- FDA office
- Division of Human and Animal Food Operations East VI
- Subject
- Not available
- Product
- Food & Beverages
- CMS ID
- 679972
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
PepsiCo, Inc.
MARCS-CMS 679972 —
September 10, 2024
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Food & Beverages
Recipient:
Recipient Name
Ramon Laquarta
Recipient Title
CEO
PepsiCo, Inc.
The Quaker Oats Co.
700 Anderson Hill Road
Purchase
,
NY
10577
United States
Ramon.laguarta@pepsico.com
Issuing Office:
Division of Human and Animal Food Operations East VI
United States
Secondary Issuing Offices
United States
Dear Mr. Laquarta:
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter (CMS#679972), dated June 12, 2024. Based on our evaluation, it appears that you have addressed the violation(s) by permanently closing your Danville, IL facility. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of corrections at all locations.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
LCDR Audrey DeLa Cruz
Acting, Director of Compliance
Office of Human and Animal Food
Division HAFE6
Content current as of:
09/17/2024
Regulated Product(s)
Food & Beverages